Posts

Showing posts from May, 2020

The Future of Single Cell Analysis….. COVID-19 & Its Impact….

The global single cell analysis market size is expected to reach USD 8.02 billion by 2027 , registering a CAGR of 16.9% during the forecast period, according to a new report by Grand View Research, Inc. Advancements in molecular techniques which resulted in higher accuracy, ability to perform multiple omics analyses in one cell, and automation, has lowered the barriers for implementation of single-cell analysis techniques across various end-use settings. As a result, companies are investing in introducing novel solutions to accelerate the identification and quantification of genetic information in individual cells for research programs, thereby contributing to revenue growth in this market. Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SA

Demand for North America and Europe Stroke Diagnostics and Impact of COVID-19……..

The North America and Europe stroke diagnostics market size is expected to reach USD 2.35 billion by 2024 , according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.2% over the forecast period. Rising geriatric population in countries like U.S. and Germany has led to high growth of the market. Geriatric population in U.S. is anticipated to rise to around 98 million by 2060. The most common concern for the governments of all Covid-19 hit nations is the excruciating need to screen for and test large numbers of patients for possible Sars-Cov-2 infection. As a result, most of them are facing major shortages in the supply for diagnostic kits to test for the virus. Diagnostics virology entities are under immense pressure to provide reliable testing kits, and there is a surge in demand for in-vitro or point-of-care testing capacities by labs across a large number of countries. The report will account for Covid19 as a key market contributor. Un

How much will the Medical Image Analysis Software industry be worth in the Future????

The global medical image analysis software market size is expected to reach USD 4.51 billion by 2024, according to a new report by Grand View Research, Inc., registering an 8.1% CAGR during the forecast period. Increasing incidence of chronic diseases creates demand for effective diagnostics solutions, which spurs demand for medical image analysis software. High growth of the industry is majorly attributed to increase in usage and uptake of image analysis solutions for diagnosis. In addition, shifting focus to provide enhanced care has led to incorporation of various computer aided diagnosis systems, which is further contributing toward growth. Introduction of technologically advanced products such as 3D/4D platforms and multimodality imaging platforms is also presumed to augment growth over the coming years. Various benefits such as flexibility and high-resolution images, along with convenient use of multi-modal integrated workflows, are expected to bolster demand and increase